| 000 | 03599naa a22005417i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-MLS-039 | ||
| 003 | local | ||
| 005 | 20261005174904.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2020 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.21037/atm-20-1855 _2doi |
|
| 035 | _a(local)EuropePMC:PMC7290560 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aAnna Maria Azzini _eauthor. |
|
| 245 | 1 | 2 |
_aA 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine. / _cAnna Maria Azzini; Romolo Marco Dorizzi; Piersandro Sette [and others]. |
| 264 | 1 |
_a[Place of publication not identified] : _bAME Publications, _c2020. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aBiomarkers to guide antibiotic treatment decisions have been proposed as an effective way to enhancing a more appropriate use of antibiotics. As a biomarker, procalcitonin (PCT) has been found to have good specificity to distinguish bacterial from non-bacterial inflammations. Decisions regarding antibiotic use in an individual patient are complex and should be based on the pre-test probability for bacterial infection, the severity of presentation and the results of PCT serum concentration. In the context of a high pre-test probability for bacterial infections and/or a high-risk patient with sepsis, monitoring of PCT over time helps to track the resolution of infection and decisions regarding early stop of antibiotic treatment. As outlined by the Evidence Based Laboratory Medicine (EBLM), not only the pre-test probability but also the positive likelihood ratio influence the performance of a test do be really diagnostic. This aspect should be taken into account in the interpretation of the results of clinical trials evaluating the performance of PCT in guiding antibiotic therapy. | |
| 540 |
_aCreative Commons Attribution-NonCommercial-NoDerivatives. See the linked licence for the applicable terms. _uhttps://creativecommons.org/licenses/by-nc-nd/4.0/ |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Medical Laboratory Science. | ||
| 650 | 4 | _aAntibiotic Therapy | |
| 650 | 4 | _aProcalcitonin (Pct) | |
| 650 | 4 | _aEvidence Based Laboratory Medicine (Eblm) | |
| 653 | _aB. Sc. Medical Laboratory Science | ||
| 653 | _aUMUN open access collection | ||
| 653 | _aclinical chemistry | ||
| 655 | 4 | _aReview articles. | |
| 700 | 0 |
_aRomolo Marco Dorizzi _eauthor. |
|
| 700 | 0 |
_aPiersandro Sette _eauthor. |
|
| 700 | 0 |
_aMarta Vecchi _eauthor. |
|
| 700 | 0 |
_aIlaria Coledan _eauthor. |
|
| 700 | 0 |
_aElda Righi _eauthor. |
|
| 700 | 0 |
_aEvelina Tacconelli _eauthor. |
|
| 773 | 0 |
_tAnnals of translational medicine _gVol. 8, no. 9, (2020), pages/article 610 _x2305-5839 |
|
| 856 | 4 | 0 |
_uhttps://europepmc.org/articles/PMC7290560 _yRead open-access publication _zOpen access. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from Europe PMC metadata. _g20261005 _khttps://europepmc.org/articles/PMC7290560 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c1181 _d1181 |
||